S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:ATRIAtrion Stock Price, Forecast & News

$644.60
-18.40 (-2.78 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$644.60
Now: $644.60
$659.40
50-Day Range
$619.53
MA: $642.74
$667.33
52-Week Range
$579.00
Now: $644.60
$846.15
Volume3,293 shs
Average Volume6,742 shs
Market Capitalization$1.18 billion
P/E Ratio34.02
Dividend Yield0.94%
Beta0.15
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Read More
Atrion logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.97 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
CUSIP04990410
Phone972-390-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$155.07 million
Cash Flow$25.62 per share
Book Value$128.24 per share

Profitability

Net Income$36.76 million

Miscellaneous

Employees570
Market Cap$1.18 billion
Next Earnings Date11/6/2020 (Estimated)
OptionableNot Optionable
$644.60
-18.40 (-2.78 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Atrion (NASDAQ:ATRI) Frequently Asked Questions

How has Atrion's stock been impacted by Coronavirus (COVID-19)?

Atrion's stock was trading at $667.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ATRI stock has decreased by 0.3% and is now trading at $665.00.
View which stocks have been most impacted by COVID-19
.

When is Atrion's next earnings date?

Atrion is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Atrion
.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) announced its quarterly earnings results on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share (EPS) for the quarter. The medical instruments supplier earned $38.88 million during the quarter. Atrion had a net margin of 22.70% and a return on equity of 14.98%.
View Atrion's earnings history
.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Friday, May 22nd. Investors of record on Monday, June 15th will be given a dividend of $1.55 per share on Tuesday, June 30th. This represents a $6.20 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date is Friday, June 12th.
View Atrion's dividend history
.

Has Atrion been receiving favorable news coverage?

Media coverage about ATRI stock has been trending neutral recently, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Atrion earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Atrion
.

Who are some of Atrion's key competitors?

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), AbbVie (ABBV), ABM Industries (ABM), Caterpillar (CAT), Dominion Energy (D), Walt Disney (DIS), Consolidated Edison (ED), Gilead Sciences (GILD) and Altria Group (MO).

Who are Atrion's key executives?

Atrion's management team includes the following people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 81)
  • Mr. David A. Battat, Pres & CEO (Age 49)
  • Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Who are Atrion's major shareholders?

Atrion's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (1.38%), ProShare Advisors LLC (0.58%), Bessemer Group Inc. (0.24%), Raymond James Financial Services Advisors Inc. (0.22%), Swiss National Bank (0.18%) and First Trust Advisors LP (0.16%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland, John P Stupp Jr and Ronald Nicholas Spaulding.
View institutional ownership trends for Atrion
.

Which major investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including ProShare Advisors LLC, Bessemer Group Inc., Principal Financial Group Inc., New York State Common Retirement Fund, UBS Group AG, Capital Analysts LLC, US Bancorp DE, and Russell Investments Group Ltd..
View insider buying and selling activity for Atrion
.

Which major investors are buying Atrion stock?

ATRI stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, First Trust Advisors LP, MAI Capital Management, Krane Funds Advisors LLC, Raymond James & Associates, M&T Bank Corp, Swiss National Bank, and Virtu Financial LLC.
View insider buying and selling activity for Atrion
.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $665.00.

How big of a company is Atrion?

Atrion has a market capitalization of $1.22 billion and generates $155.07 million in revenue each year. Atrion employs 570 workers across the globe.

What is Atrion's official website?

The official website for Atrion is www.atrioncorp.com.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.